Skip to main content

Animations

MJFF Publications

4361 - 4370 of 6466 Results
Title
Year
  • Year
  • 2020
  • 2026
  • 2023
  • 2017
  • 2021
  • 2019
  • 2018
  • 2025
  • 2020
  • 2018
  • Summary Details
    OPEN
    Title: MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28143
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Multi-tissue transcriptomic aging atlas reveals predictive aging biomarkers in the killifish
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-026-01074-6
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Disrupted‐in‐schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first‐episode psychosis
    Journal Name: Psychiatry and Clinical Neurosciences
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/pcn.13594
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2017.00100
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Tandem Ring Opening/Intramolecular [2 + 2] Cycloaddition Reaction for the Synthesis of Cyclobutane Fused Thiazolino-2-Pyridones
    Journal Name: The Journal of Organic Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.joc.1c01875
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.ra118.005008
    Citation Count: 82
  • Summary Details
    OPEN
    Title: The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2018.00064
    Citation Count: 38
  • Summary Details
    OPEN
    Title: A framework to standardize gait study protocols in Parkinson's disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/1877718x241305626
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain
    Journal Name: Current Research in Pharmacology and Drug Discovery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.crphar.2020.04.001
    Citation Count: 22
  • Summary Details
    OPEN
    Title: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
    Journal Name: Journal of Experimental Medicine
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1084/jem.20180484
    Citation Count: 104
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.